Herpes Zoster as a Risk Factor for Incident Giant Cell Arteritis

Histopathologic studies have implicated herpes zoster (HZ) as a causative organism of giant cell arteritis (GCA). The purpose of this study was to assess the epidemiologic association of HZ events with incident GCA.

[1]  Tyler J. VanderWeele,et al.  Sensitivity Analysis in Observational Research: Introducing the E-Value , 2017, Annals of Internal Medicine.

[2]  J. Baddley,et al.  Herpes Zoster and the Risk of Stroke in Patients With Autoimmune Diseases , 2017, Arthritis & rheumatology.

[3]  P. Merkel,et al.  Infections and the risk of incident giant cell arteritis: a population-based, case-control study , 2016, Annals of the rheumatic diseases.

[4]  M. Broder,et al.  Corticosteroid-related adverse events in patients with giant cell arteritis: A claims-based analysis. , 2016, Seminars in arthritis and rheumatism.

[5]  N. Acharya,et al.  Assessment of the Accuracy of Using ICD-9 Codes to Identify Uveitis, Herpes Zoster Ophthalmicus, Scleritis, and Episcleritis. , 2016, JAMA ophthalmology.

[6]  E. Hedley‐Whyte,et al.  Varicella Zoster Virus Infection in Granulomatous Arteritis of the Aorta. , 2016, The Journal of infectious diseases.

[7]  D. Gilden,et al.  Blinded search for varicella zoster virus in giant cell arteritis (GCA)-positive and GCA-negative temporal arteries , 2016, Journal of the Neurological Sciences.

[8]  D. Pisapia,et al.  VZV, temporal arteritis, and clinical practice: False positive immunohistochemical detection due to antibody cross-reactivity. , 2016, Experimental and molecular pathology.

[9]  E. Lavi,et al.  Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis , 2015, Neurology.

[10]  H. Grossniklaus,et al.  Analysis of Varicella-Zoster Virus in Temporal Arteries Biopsy Positive and Negative for Giant Cell Arteritis. , 2015, JAMA neurology.

[11]  F. Sloan,et al.  Effect of Diabetes Mellitus on Giant Cell Arteritis , 2015, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[12]  K. Schmader,et al.  Long-term persistence of zoster vaccine efficacy. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  Hyon K. Choi,et al.  The risk of deep venous thrombosis and pulmonary embolism in giant cell arteritis: a general population-based study , 2014, Annals of the rheumatic diseases.

[14]  L. Wilkins Herpes zoster as a risk factor for stroke and TIA: A retrospective cohort study in the UK , 2014, Neurology.

[15]  M. Brown,et al.  Herpes zoster as a risk factor for stroke and TIA , 2014, Neurology.

[16]  A. Cunningham,et al.  Analysis of T Cell Responses during Active Varicella-Zoster Virus Reactivation in Human Ganglia , 2013, Journal of Virology.

[17]  C. Weyand,et al.  Immune mechanisms in medium and large-vessel vasculitis , 2013, Nature Reviews Rheumatology.

[18]  G. Hunder,et al.  Clinical features of polymyalgia rheumatica and giant cell arteritis , 2012, Nature Reviews Rheumatology.

[19]  Martin Kulldorff,et al.  Herpes zoster and postherpetic neuralgia surveillance using structured electronic data. , 2011, Mayo Clinic proceedings.

[20]  Y. J. Liao,et al.  Giant cell arteritis: immune and vascular aging as disease risk factors , 2011, Arthritis research & therapy.

[21]  S. Bernatsky,et al.  The Accuracy of Administrative Data Diagnoses of Systemic Autoimmune Rheumatic Diseases , 2011, The Journal of Rheumatology.

[22]  S. Gabriel,et al.  Incidence of herpes zoster in patients with giant cell arteritis: a population-based cohort study. , 2010, Rheumatology.

[23]  Herng‐Ching Lin,et al.  Increased Risk of Stroke After a Herpes Zoster Attack: A Population-Based Follow-Up Study , 2009, Stroke.

[24]  Javier Martín,et al.  Epidemiology of giant cell arteritis and polymyalgia rheumatica. , 2009, Arthritis and rheumatism.

[25]  M. Elkind,et al.  The varicella zoster virus vasculopathies: Clinical, CSF, imaging, and virologic features , 2009, Neurology.

[26]  B. Fernández-Gutiérrez,et al.  Human parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: analysis with quantitative real time polymerase chain reaction , 2005, Annals of the rheumatic diseases.

[27]  J. Stone,et al.  No detection of parvovirus B19 or herpesvirus DNA in giant cell arteritis. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[28]  M. Esiri,et al.  Absence of detection of Varicella-Zoster virus DNA in temporal artery biopsies obtained from patients with giant cell arteritis , 2003, Journal of the Neurological Sciences.

[29]  S. Gabriel,et al.  Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. , 2003, Arthritis and rheumatism.

[30]  B. Baslund,et al.  No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis. , 2002, Rheumatology.

[31]  R. L. Font,et al.  Detection of varicella zoster virus DNA in some patients with giant cell arteritis. , 2001, Investigative ophthalmology & visual science.

[32]  C. Nordborg,et al.  Search for varicella zoster virus in giant cell arteritis , 1998, Annals of neurology.

[33]  M. Russo,et al.  Correlation between infection and the onset of the giant cell (temporal) arteritis syndrome. A trigger mechanism? , 1995, Arthritis and rheumatism.

[34]  A. B. Hill The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.

[35]  S. Gabriel,et al.  Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. , 2008, Arthritis and rheumatism.

[36]  B. Thiers A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults , 2006 .

[37]  B. Yawn,et al.  Comparing shingles incidence and complication rates from medical record review and administrative database estimates: how close are they? , 2011, American journal of epidemiology.